Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Catherine J. Bakewell
Based on 5 articles published since 2009
(Why 5 articles?)
||||
Expertise Level
The expertise of Catherine J. Bakewell ranks in the
  • Top 6.8%
  • ... of 59,372 published authors worldwide on Psoriasis
  • ... from 2009 through 2019
  • ... based on contributions to 5 articles on the topic.
Graphical view (beta)
Aliases Bakewell, Catherine J   ·   Bakewell, Catherine
Work Locations
Details
Most likely:    Intermountain Medical Center      
2018
  • University of Florida College of Medicine, 653-1 West 8th St., LRC 2nd Floor L-14, Jacksonville, FL 32209. Electronic address: · Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Canada. · University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. · Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitación, Mexico City, Mexico. · Intermountain Healthcare, Salt Lake City, UT. · Pubmed 29573849
  • Division of Rheumatology, University of Florida College of Medicine, Jacksonville, 653-1 West 8th St., LRC 2nd Floor L-14, Jacksonville, FL, 32209. Electronic address: · Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Canada. · University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. · Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitación, Mexico City, Mexico. · Intermountain Healthcare, Salt Lake City, UT. · Pubmed 29429762
2019
  • From the Intermountain Healthcare Medical Group, Salt Lake City, Utah, USA; University of Ottawa, Ottawa, Ontario, Canada, University of California, Los Angeles, California, USA; Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; University of Florida College of Medicine, Jacksonville, Florida, USA. Funding: This review article was sponsored by Novartis Pharmaceuticals Corporation. Conflict of interest disclosure: C. Bakewell has received consultancy fees from and/or served on speakers bureaus for AbbVie, Novartis Pharmaceuticals Corporation, Pfizer, and Sanofi Genzyme/Regeneron. S. Z. Aydin has received honoraria from Abbvie, Novartis, Pfizer, UCB, Janssen, Lilly, and Celgene. V. K. Ranganath has served on the Data and Safety Monitoring Board for Amgen, has received consultancy fees from Bristol-Myers Squibb; and has received grants for investigator-initiated studies from Genentech, Mallinckrodt, and Pfizer. L. Eder has received research or educational grants and/or consultancy fees from Amgen, Abbvie, Janssen, Pfizer, Novartis, UCB, Celgene, and Eli Lily. G. S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation. Address correspondence to Catherine Bakewell, MD, RhMSUS, Intermountain Healthcare Medical Group, Salt Lake Clinic, 389 South 900 East, Salt Lake City, UT 84102. Email: · Pubmed 31676700
Probable:    University of Florida Jacksonville   Contact    
2013
  • From the Division of Rheumatology, University of Florida College of Medicine, Jacksonville, Florida, USA. · Pubmed 24187105
2019
  • From the Intermountain Healthcare Medical Group, Salt Lake City, Utah, USA; University of Ottawa, Ottawa, Ontario, Canada, University of California, Los Angeles, California, USA; Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; University of Florida College of Medicine, Jacksonville, Florida, USA. Funding: This review article was sponsored by Novartis Pharmaceuticals Corporation. Conflict of interest disclosure: C. Bakewell has received consultancy fees from and/or served on speakers bureaus for AbbVie, Novartis Pharmaceuticals Corporation, Pfizer, and Sanofi Genzyme/Regeneron. S. Z. Aydin has received honoraria from Abbvie, Novartis, Pfizer, UCB, Janssen, Lilly, and Celgene. V. K. Ranganath has served on the Data and Safety Monitoring Board for Amgen, has received consultancy fees from Bristol-Myers Squibb; and has received grants for investigator-initiated studies from Genentech, Mallinckrodt, and Pfizer. L. Eder has received research or educational grants and/or consultancy fees from Amgen, Abbvie, Janssen, Pfizer, Novartis, UCB, Celgene, and Eli Lily. G. S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation. Address correspondence to Catherine Bakewell, MD, RhMSUS, Intermountain Healthcare Medical Group, Salt Lake Clinic, 389 South 900 East, Salt Lake City, UT 84102. Email: · Pubmed 31676700
2012
  • Division of Rheumatology, University of Florida College of Medicine, Jacksonville, Florida 32209-6561, USA. · Pubmed 22298266
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Catherine J. Bakewell in 2009-2019 about Psoriasis:

  • Imaging Techniques: Options for the Diagnosis and Monitoring of Treatment of Enthesitis in Psoriatic Arthritis. 2019
  • Dactylitis: A hallmark of psoriatic arthritis. 2018
  • Enthesitis: A hallmark of psoriatic arthritis. 2018
  • Ultrasound and magnetic resonance imaging in the evaluation of psoriatic dactylitis: status and perspectives. 2013
  • The ultrasound imaging module: a report from the GRAPPA 2010 annual meeting. 2012
Show List of Full Article Records
Google Searches

Learn more about Catherine J. Bakewell using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Intermountain Medical Center
University of Florida Jacksonville
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Intermountain Medical Center
2018
  • University of Florida College of Medicine, 653-1 West 8th St., LRC 2nd Floor L-14, Jacksonville, FL 32209. Electronic address: · Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Canada. · University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. · Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitación, Mexico City, Mexico. · Intermountain Healthcare, Salt Lake City, UT. · Pubmed 29573849
  • Division of Rheumatology, University of Florida College of Medicine, Jacksonville, 653-1 West 8th St., LRC 2nd Floor L-14, Jacksonville, FL, 32209. Electronic address: · Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Canada. · University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. · Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitación, Mexico City, Mexico. · Intermountain Healthcare, Salt Lake City, UT. · Pubmed 29429762
2019
  • From the Intermountain Healthcare Medical Group, Salt Lake City, Utah, USA; University of Ottawa, Ottawa, Ontario, Canada, University of California, Los Angeles, California, USA; Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; University of Florida College of Medicine, Jacksonville, Florida, USA. Funding: This review article was sponsored by Novartis Pharmaceuticals Corporation. Conflict of interest disclosure: C. Bakewell has received consultancy fees from and/or served on speakers bureaus for AbbVie, Novartis Pharmaceuticals Corporation, Pfizer, and Sanofi Genzyme/Regeneron. S. Z. Aydin has received honoraria from Abbvie, Novartis, Pfizer, UCB, Janssen, Lilly, and Celgene. V. K. Ranganath has served on the Data and Safety Monitoring Board for Amgen, has received consultancy fees from Bristol-Myers Squibb; and has received grants for investigator-initiated studies from Genentech, Mallinckrodt, and Pfizer. L. Eder has received research or educational grants and/or consultancy fees from Amgen, Abbvie, Janssen, Pfizer, Novartis, UCB, Celgene, and Eli Lily. G. S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation. Address correspondence to Catherine Bakewell, MD, RhMSUS, Intermountain Healthcare Medical Group, Salt Lake Clinic, 389 South 900 East, Salt Lake City, UT 84102. Email: · Pubmed 31676700
University of Florida Jacksonville
2013
  • From the Division of Rheumatology, University of Florida College of Medicine, Jacksonville, Florida, USA. · Pubmed 24187105
2019
  • From the Intermountain Healthcare Medical Group, Salt Lake City, Utah, USA; University of Ottawa, Ottawa, Ontario, Canada, University of California, Los Angeles, California, USA; Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; University of Florida College of Medicine, Jacksonville, Florida, USA. Funding: This review article was sponsored by Novartis Pharmaceuticals Corporation. Conflict of interest disclosure: C. Bakewell has received consultancy fees from and/or served on speakers bureaus for AbbVie, Novartis Pharmaceuticals Corporation, Pfizer, and Sanofi Genzyme/Regeneron. S. Z. Aydin has received honoraria from Abbvie, Novartis, Pfizer, UCB, Janssen, Lilly, and Celgene. V. K. Ranganath has served on the Data and Safety Monitoring Board for Amgen, has received consultancy fees from Bristol-Myers Squibb; and has received grants for investigator-initiated studies from Genentech, Mallinckrodt, and Pfizer. L. Eder has received research or educational grants and/or consultancy fees from Amgen, Abbvie, Janssen, Pfizer, Novartis, UCB, Celgene, and Eli Lily. G. S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation. Address correspondence to Catherine Bakewell, MD, RhMSUS, Intermountain Healthcare Medical Group, Salt Lake Clinic, 389 South 900 East, Salt Lake City, UT 84102. Email: · Pubmed 31676700
2012
  • Division of Rheumatology, University of Florida College of Medicine, Jacksonville, Florida 32209-6561, USA. · Pubmed 22298266
8 Other Locations Show
Yearly article counts 12000011000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.